State funds trial of psilocybin-assisted psychotherapy

May 16, 2023

State funds trial of psilocybin-assisted psychotherapy

Psychiatrists at the University of Washington School of Medicine are designing a trial to study the medical use of psilocybin, after Washington legislators passed a law that authorized the research.

"What we're anticipating is studying people who are veterans or first-responders, who meet diagnostic criteria for PTSD, post-traumatic stress disorder, (and) who also meet diagnostic criteria for alcohol-use disorder," said Dr. Nathan Sackett, acting assistant professor in psychiatry & behavioral sciences.

The trial is expected to start by Jan. 1, 2025. In a blog post, learn more about the trial and its impetus.

Download broadcast-ready soundbites on psilocybin-assisted psychotherapy.

Getty Images

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images from Thinkstock but cannot grant republishing rights. You may not republish single image files credited to Thinkstock.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or